CJC1295 5mg + Ipamorelin 5mg

CJC1295 5mg + Ipamorelin 5mg

Product Overview

CJC1295 5mg + Ipamorelin 5mg is a peptide combination listing that identifies two named compounds: CJC1295, stated at 5mg, and Ipamorelin, stated at 5mg. The combined stated quantity is 10mg. The product is presented for research purposes only, where applicable, and is not described as a medicine or treatment.

The two compound names are important when identifying this product. CJC1295 is associated with research into growth hormone-releasing hormone (GHRH) signalling, while Ipamorelin is a synthetic peptide studied in relation to ghrelin-receptor signalling. Although both have been investigated in growth-hormone-related research, they are distinct compounds with different scientific classifications.

The supplied product details do not specify a brand, physical format, packaging, purity, storage conditions, batch documentation or SKU. These details are deliberately left unclaimed.

Why Consider CJC1295 5mg + Ipamorelin 5mg?

The main identifying feature of this listing is that it names two compounds and specifies the quantity of each separately:

• CJC1295: 5mg

• Ipamorelin: 5mg

• Combined stated quantity: 10mg

Keeping the individual quantities clear helps distinguish this listing from products containing only one of the compounds or products offered in different strengths.

The names alone do not establish the precise formulation, physical presentation or whether the compounds are supplied together in one container or separately. Customers should check the actual product label and listing photographs, and contact the supplier if these details are important to them.

When reviewing a research product, consider whether its description clearly identifies each compound, whether the stated quantities are unambiguous and whether any supporting documentation relates to the exact product being offered.

Research Information: CJC1295 and Ipamorelin

CJC1295 is a synthetic peptide associated with research into GHRH signalling. The GHRH pathway is involved in the regulation of growth hormone release. Research literature on CJC-1295 includes studies examining its pharmacological characteristics and changes in growth-hormone-related measurements. These findings should be interpreted in the context of the particular compound and study design.

Ipamorelin is a synthetic pentapeptide investigated as a growth hormone secretagogue. It is associated with the ghrelin receptor, also known as the growth hormone secretagogue receptor (GHS-R). Its mechanism of interest differs from the GHRH-related pathway associated with CJC1295.

Researchers comparing these compounds should consult the scientific literature for each substance independently. A study of one compound does not establish the properties or outcomes of the other, and evidence about either compound individually does not establish the effects of this specific combination.

Useful starting points include the PubMed biomedical literature database, where readers can search for publications on CJC-1295 and Ipamorelin, and the National Library of Medicine for information about biomedical research resources.

Quality, Documentation and Product Transparency

Accurate product identification is an important part of evaluating research materials. For this combination, the supplied information confirms the two compound names and their stated individual quantities. It does not confirm independent testing, purity results, manufacturing standards or batch-specific documentation.

If a Certificate of Analysis (CoA) is offered, customers should check that it identifies the relevant product and batch. The report should make its analytical method, test date and results clear. A document relating to one compound or a different batch should not automatically be treated as verification of this combination.

No claim of GMP certification, pharmaceutical-grade status, independent laboratory testing or a particular purity percentage is made here because supporting evidence has not been provided.

For questions about the product listing or available documentation, customers can use the Peptide Depot Contact Us page.

Buying with Confidence

When evaluating research-product suppliers in the United Kingdom, look for clear compound identification, transparent quantities, accessible customer support and product documentation that can be checked. Customers should also review the store’s applicable checkout, delivery and returns information before placing an order.

The Medicines and Healthcare products Regulatory Agency (MHRA) provides official information about medicines regulation in the UK. Its guidance is useful for understanding the distinction between research materials and products supplied as medicines. The GOV.UK guidance on unlicensed medicinal products provides further regulatory context.

Important Research-Use Notice

CJC1295 5mg + Ipamorelin 5mg is presented as a research product, where applicable. It is not described here as a medicine or treatment. This description does not provide human-administration instructions or make claims about medical outcomes. Customers should verify the product’s status, documentation and applicable legal requirements before purchase.